Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice

Diabetologia

Volumn 58, Issue 11, 2015, Pages 2637-2646

  Kooijman, Sander ^a   Wang, Yanan ^a   Parlevliet, Edwin T ^a,b   Boon, Mariëtte R ^a   Edelschaap, David ^a   Snaterse, Gido ^a   Pijl, Hanno ^a   Romijn, Johannes A ^b   Rensen, Patrick C N ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Brown adipose tissue; Exendin 4; GLP 1; Mice; Triacylglycerol

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 1; GLUCAGON LIKE PEPTIDE 1; INCRETIN; INSULIN; ION CHANNEL; MITOCHONDRIAL PROTEIN; PEPTIDE; UCP1 PROTEIN, MOUSE; VENOM;

ANIMAL EXPERIMENT; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; GLUCOSE TRANSPORT; LIPID TRANSPORT; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THERMOGENESIS; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; AGONISTS; ANIMAL; BODY COMPOSITION; C57BL MOUSE; DRUG EFFECTS; MALE; METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE, BROWN; ANIMALS; BODY COMPOSITION; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; GLUCOSE; INCRETINS; INSULIN; ION CHANNELS; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; PEPTIDES; SIGNAL TRANSDUCTION; TRIGLYCERIDES; UNCOUPLING PROTEIN 1; VENOMS;

EID: 84942991914     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3727-0     Document Type: Article

References (31)

1. Gallwitz B (2011) Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents. Drugs 71:1675–1688
2. Hwa JJ, Ghibaudi L, Williams P, Witten MB, Tedesco R, Strader CD (1998) Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation. Peptides 19:869–875
3. Turton MD, O'Shea D, Gunn I et al (1996) A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69–72
4. Knauf C, Cani PD, Perrin C et al (2005) Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest 115:3554–3563
5. Sandoval DA, Bagnol D, Woods SC, D'Alessio DA, Seeley RJ (2008) Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 57:2046–2054
6. Parlevliet ET, de Leeuw van Weenen JE, Romijn JA, Pijl H (2010) GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet. Am J Physiol Endocrinol Metab 299:E318–E324
7. Boon MR, van den Berg SA, Wang Y et al (2013) BMP7 activates brown adipose tissue and reduces diet-induced obesity only at subthermoneutrality. PLoS One 8, e74083
8. Geerling JJ, Boon MR, van der Zon GC et al (2014) Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice. Diabetes 63:880–891
9. Bartelt A, Bruns OT, Reimer R et al (2011) Brown adipose tissue activity controls triglyceride clearance. Nat Med 17:200–205
10. Emanuelli B, Vienberg SG, Smyth G et al (2014) Interplay between FGF21 and insulin action in the liver regulates metabolism. J Clin Invest 124:515–527
11. Khedoe PP, Hoeke G, Kooijman S et al (2015) Brown adipose tissue takes up plasma triglycerides mostly after lipolysis. J Lipid Res 56:51–59
12. Lockie SH, Heppner KM, Chaudhary N et al (2012) Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling. Diabetes 61:2753–2762
13. Beiroa D, Imbernon M, Gallego R et al (2014) GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes 63:3346–3358
14. Coomans CP, Biermasz NR, Geerling JJ et al (2011) Stimulatory effect of insulin on glucose uptake by muscle involves the central nervous system in insulin-sensitive mice. Diabetes 60:3132–3140
15. Rensen PC, Herijgers N, Netscher MH, Meskers SC, van Eck M, van Berkel TJ (1997) Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J Lipid Res 38:1070–1084
16. Van Klinken JB, van den Berg SA, Havekes LM, van Willems DK (2012) Estimation of activity related energy expenditure and resting metabolic rate in freely moving mice from indirect calorimetry data. PLoS One 7, e36162
17. Al-Barazanji KA, Arch JR, Buckingham RE, Tadayyon M (2000) Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats. Obes Res 8:317–323
18. Nogueiras R, Perez-Tilve D, Veyrat-Durebex C et al (2009) Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity. J Neurosci 29:5916–5925
19. Giordano A, Frontini A, Cinti S (2008) Adipose organ nerves revealed by immunohistochemistry. Methods Mol Biol 456:83–95
20. Challa TD, Beaton N, Arnold M, Rudofsky G, Langhans W, Wolfrum C (2012) Regulation of adipocyte formation by GLP-1/GLP-1R signaling. J Biol Chem 287:6421–6430
21. Korsheninnikova E, van der Zon GC, Voshol PJ et al (2006) Sustained activation of the mammalian target of rapamycin nutrient sensing pathway is associated with hepatic insulin resistance, but not with steatosis, in mice. Diabetologia 49:3049–3057
22. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN (1988) Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37:1163–1167
23. van Baak MA (2001) The peripheral sympathetic nervous system in human obesity. Obes Rev 2:3–14
24. Bartness TJ, Song CK (2007) Brain-adipose tissue neural crosstalk. Physiol Behav 91:343–351
25. Goke R, Larsen PJ, Mikkelsen JD, Sheikh SP (1995) Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 7:2294–2300
26. Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84:277–359
27. Parlevliet ET, Wang Y, Geerling JJ et al (2012) GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice. PLoS One 7, e49152
28. Tachibana T, Oikawa D, Adachi N, Boswell T, Furuse M (2007) Intracerebroventricular injection of glucagon-like peptide-1 changes lipid metabolism in chicks. Comp Biochem Physiol A Mol Integr Physiol 147:1104–1108
29. Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP (2012) The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci 32:4812–4820
30. Virtue S, Even P, Vidal-Puig A (2012) Below thermoneutrality, changes in activity do not drive changes in total daily energy expenditure between groups of mice. Cell Metab 16:665–671
31. Berbee JF, Boon MR, Khedoe PP et al (2015) Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat Commun 6:6356